K. Kaniga Et Al. , "Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates," JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1, 2022
Kaniga, K. Et Al. 2022. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates. JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1 .
Kaniga, K., Hasan, R., Jou, R., Vasiliauskiene, E., Chuchottaworn, C., Ismail, N., ... Metchock, B.(2022). Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates. JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1.
Kaniga, Kone Et Al. "Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates," JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1, 2022
Kaniga, Kone Et Al. "Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates." JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1, 2022
Kaniga, K. Et Al. (2022) . "Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates." JOURNAL OF CLINICAL MICROBIOLOGY , vol.60, no.1.
@article{article, author={Kone Kaniga Et Al. }, title={Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates}, journal={JOURNAL OF CLINICAL MICROBIOLOGY}, year=2022}